Goldman Sachs Initiates Coverage on Agilent Technologies Inc (A)
Goldman Sachs has initiated coverage on Agilent Technologies Inc (A) with a Buy rating.
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Agilent Technologies Inc.
Last Updated: Dec 11, 2025, 11:09 PM · Source: Finnhub.io
Goldman Sachs has initiated coverage on Agilent Technologies Inc (A) with a Buy rating.
Morgan Stanley initiates coverage on Agilent Technologies Inc with an Overweight rating.
Agilent Technologies Inc (A) announces a quarterly dividend of $0.26 per share, reflecting a 2.8% increase.
Agilent Technologies Inc (A) misses Q4 earnings expectations with EPS of $1.59.
Agilent Technologies Inc (A) announces a quarterly dividend of $0.25 per share, payable on October 21, 2025.